Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95

1.

Magnetic Resonance Imaging only Workflow for Radiotherapy Simulation and Planning in Prostate Cancer.

Kerkmeijer LGW, Maspero M, Meijer GJ, van der Voort van Zyp JRN, de Boer HCJ, van den Berg CAT.

Clin Oncol (R Coll Radiol). 2018 Nov;30(11):692-701. doi: 10.1016/j.clon.2018.08.009. Epub 2018 Sep 21.

PMID:
30244830
2.

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.

Maspero M, Seevinck PR, Willems NJW, Sikkes GG, de Kogel GJ, de Boer HCJ, van der Voort van Zyp JRN, van den Berg CAT.

Radiat Oncol. 2018 Jun 5;13(1):105. doi: 10.1186/s13014-018-1029-7.

3.

The human kidney capsule contains a functionally distinct mesenchymal stromal cell population.

Leuning DG, Engelse MA, Lievers E, Bijkerk R, Reinders MEJ, de Boer HC, van Kooten C, Rabelink TJ.

PLoS One. 2017 Dec 5;12(12):e0187118. doi: 10.1371/journal.pone.0187118. eCollection 2017.

4.

Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development.

Khedoe PPSJ, de Kleijn S, van Oeveren-Rietdijk AM, Plomp JJ, de Boer HC, van Pel M, Rensen PCN, Berbée JFP, Hiemstra PS.

PLoS One. 2017 Sep 14;12(9):e0183741. doi: 10.1371/journal.pone.0183741. eCollection 2017.

5.

Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.

Boels MGS, Koudijs A, Avramut MC, Sol WMPJ, Wang G, van Oeveren-Rietdijk AM, van Zonneveld AJ, de Boer HC, van der Vlag J, van Kooten C, Eulberg D, van den Berg BM, IJpelaar DHT, Rabelink TJ.

Am J Pathol. 2017 Nov;187(11):2430-2440. doi: 10.1016/j.ajpath.2017.07.020. Epub 2017 Aug 22.

6.

Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy.

Maspero M, van den Berg CAT, Zijlstra F, Sikkes GG, de Boer HCJ, Meijer GJ, Kerkmeijer LGW, Viergever MA, Lagendijk JJW, Seevinck PR.

Phys Med Biol. 2017 Oct 3;62(20):7981-8002. doi: 10.1088/1361-6560/aa875f.

PMID:
28825917
7.

Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.

Leuning DG, Reinders ME, Li J, Peired AJ, Lievers E, de Boer HC, Fibbe WE, Romagnani P, van Kooten C, Little MH, Engelse MA, Rabelink TJ.

Stem Cells Transl Med. 2017 Feb;6(2):405-418. doi: 10.5966/sctm.2016-0053. Epub 2016 Sep 20.

8.

Promoting Tropoelastin Expression in Arterial and Venous Vascular Smooth Muscle Cells and Fibroblasts for Vascular Tissue Engineering.

Rothuizen TC, Kemp R, Duijs JM, de Boer HC, Bijkerk R, van der Veer EP, Moroni L, van Zonneveld AJ, Weiss AS, Rabelink TJ, Rotmans JI.

Tissue Eng Part C Methods. 2016 Oct;22(10):923-931. doi: 10.1089/ten.TEC.2016.0173. Epub 2016 Sep 28.

PMID:
27604583
9.

Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies.

Pont MJ, Honders MW, Kremer AN, van Kooten C, Out C, Hiemstra PS, de Boer HC, Jager MJ, Schmelzer E, Vries RG, Al Hinai AS, Kroes WG, Monajemi R, Goeman JJ, Böhringer S, Marijt WA, Falkenburg JH, Griffioen M.

PLoS One. 2016 May 12;11(5):e0155165. doi: 10.1371/journal.pone.0155165. eCollection 2016.

10.

Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.

Spronk HM, De Jong AM, Verheule S, De Boer HC, Maass AH, Lau DH, Rienstra M, van Hunnik A, Kuiper M, Lumeij S, Zeemering S, Linz D, Kamphuisen PW, Ten Cate H, Crijns HJ, Van Gelder IC, van Zonneveld AJ, Schotten U.

Eur Heart J. 2017 Jan 1;38(1):38-50. doi: 10.1093/eurheartj/ehw119. Epub 2016 Apr 12.

PMID:
27071821
11.

Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression.

de Bruin RG, Shiue L, Prins J, de Boer HC, Singh A, Fagg WS, van Gils JM, Duijs JM, Katzman S, Kraaijeveld AO, Böhringer S, Leung WY, Kielbasa SM, Donahue JP, van der Zande PH, Sijbom R, van Alem CM, Bot I, van Kooten C, Jukema JW, Van Esch H, Rabelink TJ, Kazan H, Biessen EA, Ares M Jr, van Zonneveld AJ, van der Veer EP.

Nat Commun. 2016 Mar 31;7:10846. doi: 10.1038/ncomms10846.

12.

The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression.

de Bruin RG, van der Veer EP, Prins J, Lee DH, Dane MJ, Zhang H, Roeten MK, Bijkerk R, de Boer HC, Rabelink TJ, van Zonneveld AJ, van Gils JM.

Sci Rep. 2016 Feb 24;6:21643. doi: 10.1038/srep21643.

13.

Automated daily breath hold stability measurements by real-time imaging in radiotherapy of breast cancer.

de Boer HC, van den Bongard DJ, van Asselen B.

Radiother Oncol. 2016 Apr;119(1):61-4. doi: 10.1016/j.radonc.2016.02.012. Epub 2016 Feb 16.

PMID:
26900093
14.

Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer.

Cobben DC, de Boer HC, Tijssen RH, Rutten EG, van Vulpen M, Peerlings J, Troost EG, Hoffmann AL, van Lier AL.

Technol Cancer Res Treat. 2016 Dec;15(6):NP47-NP60. Epub 2015 Nov 19. Review.

PMID:
26589726
15.

Environmental impacts of innovative dairy farming systems aiming at improved internal nutrient cycling: A multi-scale assessment.

de Vries W, Kros J, Dolman MA, Vellinga TV, de Boer HC, Gerritsen AL, Sonneveld MPW, Bouma J.

Sci Total Environ. 2015 Dec 1;536:432-442. doi: 10.1016/j.scitotenv.2015.07.079. Epub 2015 Jul 29.

PMID:
26231773
16.

LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application.

Pont MJ, Hobo W, Honders MW, van Luxemburg-Heijs SA, Kester MG, van Oeveren-Rietdijk AM, Schaap N, de Boer HC, van Bergen CA, Dolstra H, Falkenburg JH, Griffioen M.

Haematologica. 2015 Oct;100(10):e419-22. doi: 10.3324/haematol.2015.125021. Epub 2015 Jun 11. No abstract available.

17.

Silencing of miRNA-126 in kidney ischemia reperfusion is associated with elevated SDF-1 levels and mobilization of Sca-1+/Lin- progenitor cells.

Bijkerk R, van Solingen C, de Boer HC, de Vries DK, Monge M, van Oeveren-Rietdijk A, van der Veer EP, Schaapherder AF, Rabelink TJ, van Zonneveld AJ.

Microrna. 2014;3(3):144-9.

PMID:
25541911
18.

TLR4 accessory molecule RP105 (CD180) regulates monocyte-driven arteriogenesis in a murine hind limb ischemia model.

Bastiaansen AJ, Karper JC, Wezel A, de Boer HC, Welten SM, de Jong RC, Peters EA, de Vries MR, van Oeveren-Rietdijk AM, van Zonneveld AJ, Hamming JF, Nossent AY, Quax PH.

PLoS One. 2014 Jun 19;9(6):e99882. doi: 10.1371/journal.pone.0099882. eCollection 2014.

19.

Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity.

Bijkerk R, van Solingen C, de Boer HC, van der Pol P, Khairoun M, de Bruin RG, van Oeveren-Rietdijk AM, Lievers E, Schlagwein N, van Gijlswijk DJ, Roeten MK, Neshati Z, de Vries AA, Rodijk M, Pike-Overzet K, van den Berg YW, van der Veer EP, Versteeg HH, Reinders ME, Staal FJ, van Kooten C, Rabelink TJ, van Zonneveld AJ.

J Am Soc Nephrol. 2014 Aug;25(8):1710-22. doi: 10.1681/ASN.2013060640. Epub 2014 Mar 7.

20.

Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.

van der Veer EP, de Bruin RG, Kraaijeveld AO, de Vries MR, Bot I, Pera T, Segers FM, Trompet S, van Gils JM, Roeten MK, Beckers CM, van Santbrink PJ, Janssen A, van Solingen C, Swildens J, de Boer HC, Peters EA, Bijkerk R, Rousch M, Doop M, Kuiper J, Schalij MJ, van der Wal AC, Richard S, van Berkel TJ, Pickering JG, Hiemstra PS, Goumans MJ, Rabelink TJ, de Vries AA, Quax PH, Jukema JW, Biessen EA, van Zonneveld AJ.

Circ Res. 2013 Oct 12;113(9):1065-75. doi: 10.1161/CIRCRESAHA.113.301302. Epub 2013 Aug 20.

PMID:
23963726

Supplemental Content

Support Center